Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

Similar articles for PubMed (Select 22990142)

1.

Adherence to escitalopram treatment in depression: a study of electronically compiled dosing histories in the 'Depression: the search for phenotypes' study.

Wessels AM, Jin Y, Pollock BG, Frank E, Lange AC, Vrijens B, Fagiolini A, Kupfer DJ, Rucci P, Kepple G, Anderton J, Buttenfield J, Bies RR.

Int Clin Psychopharmacol. 2012 Nov;27(6):291-7.

2.

Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories.

Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M.

BMJ. 2008 May 17;336(7653):1114-7. doi: 10.1136/bmj.39553.670231.25. Epub 2008 May 14.

3.

Treating depression to remission in older adults: a controlled evaluation of combined escitalopram with interpersonal psychotherapy versus escitalopram with depression care management.

Reynolds CF 3rd, Dew MA, Martire LM, Miller MD, Cyranowski JM, Lenze E, Whyte EM, Mulsant BH, Pollock BG, Karp JF, Gildengers A, Szanto K, Dombrovski AY, Andreescu C, Butters MA, Morse JQ, Houck PR, Bensasi S, Mazumdar S, Stack JA, Frank E.

Int J Geriatr Psychiatry. 2010 Nov;25(11):1134-41. doi: 10.1002/gps.2443.

4.

Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring.

Kuypers DR, Peeters PC, Sennesael JJ, Kianda MN, Vrijens B, Kristanto P, Dobbels F, Vanrenterghem Y, Kanaan N; ADMIRAD Study Team.

Transplantation. 2013 Jan 27;95(2):333-40. doi: 10.1097/TP.0b013e3182725532.

PMID:
23263559
5.

The effect of reporting methods for dosing times on the estimation of pharmacokinetic parameters of escitalopram.

Jin Y, Pollock BG, Frank E, Florian J, Kirshner M, Fagiolini A, Kupfer DJ, Gastonguay MR, Kepple G, Feng Y, Bies RR.

J Clin Pharmacol. 2009 Feb;49(2):176-84. doi: 10.1177/0091270008327538.

6.

Early non-response in patients with severe depression: escitalopram up-titration versus switch to duloxetine.

Bose A, Tsai J, Li D.

Clin Drug Investig. 2012 Jun 1;32(6):373-85. doi: 10.2165/11631890-000000000-00000.

PMID:
22559255
7.
8.
9.

[Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].

Azorin JM, Llorca PM, Despiegel N, Verpillat P.

Encephale. 2004 Mar-Apr;30(2):158-66. French.

PMID:
15107719
10.

[Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].

Favré P.

Encephale. 2012 Feb;38(1):86-96. doi: 10.1016/j.encep.2011.11.003. Epub 2011 Dec 10. Review. French.

PMID:
22381728
11.

Clinical features and efficacy of escitalopram treatment for geriatric depression.

Chen YM, Huang XM, Thompson R, Zhao YB.

J Int Med Res. 2011;39(5):1946-53.

PMID:
22117998
12.
13.

A preliminary study of luteal phase versus symptom-onset dosing with escitalopram for premenstrual dysphoric disorder.

Freeman EW, Sondheimer SJ, Sammel MD, Ferdousi T, Lin H.

J Clin Psychiatry. 2005 Jun;66(6):769-73.

PMID:
15960573
14.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
15.

Escitalopram (S-enantiomer of citalopram): clinical efficacy and onset of action predicted from a rat model.

Montgomery SA, Loft H, Sánchez C, Reines EH, Papp M.

Pharmacol Toxicol. 2001 May;88(5):282-6.

PMID:
11393591
16.

The onset of effect for escitalopram and its relevance for the clinical management of depression.

Wade A, Friis Andersen H.

Curr Med Res Opin. 2006 Nov;22(11):2101-10.

PMID:
17076970
17.

Healthcare expenditure in severely depressed patients treated with escitalopram, generic SSRIs or venlafaxine in the UK.

Wade AG, Saragoussi D, Despiégel N, François C, Guelfucci F, Toumi M.

Curr Med Res Opin. 2010 May;26(5):1161-70. doi: 10.1185/03007991003738519.

PMID:
20297951
18.

Escitalopram.

Burke WJ.

Expert Opin Investig Drugs. 2002 Oct;11(10):1477-86. Review.

PMID:
12387707
19.

Design and rationale for a randomized, controlled trial of interpersonal psychotherapy and citalopram for depression in coronary artery disease (CREATE).

Frasure-Smith N, Koszycki D, Swenson JR, Baker B, van Zyl LT, Laliberté MA, Abramson BL, Lambert J, Gravel G, Lespérance F.

Psychosom Med. 2006 Jan-Feb;68(1):87-93. Erratum in: Psychosom Med. 2007 Mar-Apr;69(2):216.

PMID:
16449416
20.

Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study.

Lee JY, Kusek JW, Greene PG, Bernhard S, Norris K, Smith D, Wilkening B, Wright JT Jr.

Am J Hypertens. 1996 Aug;9(8):719-25.

PMID:
8862216
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk